Bioelectronics Corp (BIEL)

[Probity]

Correct, it would be RecoveryRx relative to the NOPAIN Act and CMS reimbursement.

“I feel like we may be giving up on OTC sales, repeating the mistake we made in the UK.”

The UK turned into a fiasco. Although the NHS approved of the product, the local district NHS locations, being semi-autonomous, appear to have been replete with politics and whatnot…hence roadblocks. Something that would not have happened had an established and moneyed partner been in place. Their breadth and depth of experience and recognized contacts along with their lobbying resources and prowess could have saved the day.

“Revenue from NoPain act generated sales is uncertain at best, and won't even begin for several quarters (assuming our device is accepted by CMS).”

I have no problem waiting to see how it all unfolds. If one’s focus is on sales for a quarter or two or more, that’s not seeing the forest for the trees. It is a process, and should it be fortuitous for BIEL, we’ll know when we know.

The “players” are in rehearsals for the main event. We’ll see if anything evolves with the Act and CMS regarding BIEL and any prospective partners/buyout. Keep in mind that we only get to see the curtains open, and not the rehearsals/process. The Act is due to start Jan. 2025, yet the political push is on to pull that start date back to Jan. 2024.

BIEL’s past and relatively immediate future regarding sales and all the rest, is irrelevant given the Congressional Act and CMS. Who will be asked to the dance? An unknown.

All imo.